Inhibrx: Prior to Closing of Merger, All Non-101 Assets & Liabilities Will Be Spun Out From Co Into a New Publicly Traded Company, Inhibrx Biosciences
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.